Ba253BINEB in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02182635
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
74
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG:
Ba253BINEB
Sponsor
Boehringer Ingelheim